This article is more than 5 years old. Information may no longer be current.

VIDEO: Harrold reviews study on rituximab to treat RA

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WASHINGTON — At the American College of Rheumatology Annual Meeting, Leslie R. Harrold, MD, MPH, associate professor in the Department of Orthopedics and Physical Rehabilitation at the University of Massachusetts Medical School, reviewed results of a study in which rituximab improved patient-reported outcomes for patients with rheumatoid arthritis.

The study provides more information to physicians about patients who initiated rituximab after prior exposure to one or more anti-tumor necrosis factor inhibitors. She said the data can be used to assure patients who are considering rituximab, but have received multiple prior TNF inhibitors.